Last week they announce debt reduction.
Today they announce a further Equity line draw down!
Talk about the old credit card roundabout.
When is this management going to stop the bleeding and give their long suffering shareholders something positive.
Their discussions with bio pharmas is like the Forsythe Saga, never ending!!!!